Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Stokes

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|October 21, 2018
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluationMarta Quadri, Almin Silnović, Carlo Matera, et al.
ACS Chemical Neuroscience|February 9, 2024
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole ScaffoldClelia Dallanoce, Katrin Richter, Clare Stokes, et al.
The Journal of Biological Chemistry|December 24, 2013
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interfaceRoger L Papke, Nicole A Horenstein, Abhijit R Kulkarni, et al.
Addiction Biology|August 24, 2022
Betel quid: New insights into an ancient addictionClare Stokes, Jose A Pino, D Walker Hagan, et al.
Journal of Medicinal Chemistry|November 2, 2019
Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for α7 nAChRsGisela Andrea Camacho-Hernandez, Clare Stokes, Brendan M Duggan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2013
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid moleculeCan Peng, Clare Stokes, Yann S Mineur, et al.
ACS Chemical Neuroscience|June 30, 2025
Stereoisomers of Chiral Methyl-Substituted Symmetric and Asymmetric Aryl Piperazinium Compounds Exhibit Distinct Selectivity for α9 and α7 Nicotinic Acetylcholine ReceptorsHina Andleeb, Roger L Papke, Katrin Richter, et al.
Journal of Medicinal Chemistry|January 20, 2025
Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine ReceptorClaudio Papotto, Clare Stokes, Carlo Matera, et al.
European Journal of Pharmacology|November 4, 2005
Rhesus monkey alpha7 nicotinic acetylcholine receptors: comparisons to human alpha7 receptors expressed in Xenopus oocytesRoger L Papke, Thomas J McCormack, Brian A Jack, et al.
Psychopharmacology|May 28, 2014
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptorsLuisa Ponzoni, Daniela Braida, Luca Pucci, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|October 21, 2018
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluationMarta Quadri, Almin Silnović, Carlo Matera, et al.
ACS Chemical Neuroscience|February 9, 2024
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole ScaffoldClelia Dallanoce, Katrin Richter, Clare Stokes, et al.
The Journal of Biological Chemistry|December 24, 2013
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interfaceRoger L Papke, Nicole A Horenstein, Abhijit R Kulkarni, et al.
Addiction Biology|August 24, 2022
Betel quid: New insights into an ancient addictionClare Stokes, Jose A Pino, D Walker Hagan, et al.
Journal of Medicinal Chemistry|November 2, 2019
Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for α7 nAChRsGisela Andrea Camacho-Hernandez, Clare Stokes, Brendan M Duggan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2013
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid moleculeCan Peng, Clare Stokes, Yann S Mineur, et al.
ACS Chemical Neuroscience|June 30, 2025
Stereoisomers of Chiral Methyl-Substituted Symmetric and Asymmetric Aryl Piperazinium Compounds Exhibit Distinct Selectivity for α9 and α7 Nicotinic Acetylcholine ReceptorsHina Andleeb, Roger L Papke, Katrin Richter, et al.
Journal of Medicinal Chemistry|January 20, 2025
Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine ReceptorClaudio Papotto, Clare Stokes, Carlo Matera, et al.
European Journal of Pharmacology|November 4, 2005
Rhesus monkey alpha7 nicotinic acetylcholine receptors: comparisons to human alpha7 receptors expressed in Xenopus oocytesRoger L Papke, Thomas J McCormack, Brian A Jack, et al.
Psychopharmacology|May 28, 2014
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptorsLuisa Ponzoni, Daniela Braida, Luca Pucci, et al.
Pageof 6